ZLAB (STOCKS)
Zai Lab Limited American Depositary Shares
$21.360000
+0.680000 (+3.29%)
Prev close: $20.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ying Du
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,430.49M
- Employees
- 1,844
- P/E (TTM)
- -12.86
- P/B (TTM)
- 3.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
9
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.05 | $-0.07 | +0.0158 | +24.01% |
|
Sep 2025 (Q3)
|
$-0.03 | $-0.04 | +0.0144 | +32.43% |
|
Jun 2025 (Q2)
|
$-0.04 | $-0.04 | +0.0008 | +1.96% |
|
Mar 2025 (Q1)
|
$-0.04 | $-0.05 | +0.0110 | +21.57% |
Financial Statements
| Revenues | $460.16M |
| Benefits Costs and Expenses | $638.62M |
| Cost Of Revenue | $190.52M |
| Costs And Expenses | $638.62M |
| Gross Profit | $269.64M |
| Operating Expenses | $499.07M |
| Selling, General, and Administrative Expenses | $277.61M |
| Research and Development | $220.90M |
| Other Operating Expenses | $561.00K |
| Operating Income/Loss | -$229.43M |
| Income/Loss From Continuing Operations After Tax | -$175.54M |
| Income/Loss From Continuing Operations Before Tax | -$178.46M |
| Income Tax Expense/Benefit | -$2.93M |
| Net Income/Loss | -$175.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$175.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$175.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.16 |
| Diluted Earnings Per Share | -$0.16 |
| Basic Average Shares | 1,095,311,090 |
| Diluted Average Shares | 1,095,311,090 |
| Assets | $1.17B |
| Current Assets | $1.02B |
| Inventory | $74.75M |
| Other Current Assets | $944.54M |
| Noncurrent Assets | $153.10M |
| Fixed Assets | $47.39M |
| Intangible Assets | $76.14M |
| Other Non-current Assets | $29.57M |
| Liabilities | $456.88M |
| Current Liabilities | $416.17M |
| Accounts Payable | $141.61M |
| Wages | $28.49M |
| Other Current Liabilities | $246.07M |
| Noncurrent Liabilities | $40.72M |
| Equity | $715.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $715.50M |
| Liabilities And Equity | $1.17B |
| Net Cash Flow From Operating Activities | -$150.79M |
| Net Cash Flow From Operating Activities, Continuing | -$150.79M |
| Net Cash Flow From Investing Activities | $307.87M |
| Net Cash Flow From Investing Activities, Continuing | $307.87M |
| Net Cash Flow From Financing Activities | $72.35M |
| Net Cash Flow From Financing Activities, Continuing | $72.35M |
| Net Cash Flow | $229.43M |
| Net Cash Flow, Continuing | $229.43M |
| Comprehensive Income/Loss | -$196.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$196.36M |
| Other Comprehensive Income/Loss | -$196.36M |